MedAI Verdict
All comparisons

Etiometry Platform vs Implicity

An ICU team is Etiometry's buyer. Its vendor reports ICU length of stay down by up to 36%, ICU readmissions down by up to 41% and ventilation time down by up to 30%, labeled observational, and states the platform aids decisions and does not improve outcomes independently. Implicity's buyer is a cardiac device clinic, which makes it a separate purchase.

Implicity runs cloud remote monitoring for pacemakers, ICDs and insertable monitors from Abbott, Biotronik, Boston Scientific, Medtronic and MicroPort, with AI alert filtering and a heart failure risk score. Three FDA 510(k) records back it, the latest K253463 in July 2026. The home page names no EHR. Per funding coverage, the vendor says more than 250 medical centers use it and that mortality ran 26% lower than with conventional remote monitoring.

Decision support · Reviewed November 2, 2026

Etiometry Platform logo

Etiometry Platform

by Etiometry · founded 2010

ICU data platform that aggregates monitor and EHR data and runs four FDA-cleared physiologic risk indices.

IM

Implicity

by Implicity · founded 2016

Cloud platform for remote monitoring of pacemakers and ICDs, with AI alert filtering and heart failure risk scoring for device clinics.

When to pick each one

Etiometry Platform

  • Vendor reports ICU stays shorter by up to 36%
  • Data aggregation across ICU monitors, devices and EHR
  • ICU readmissions down up to 41%, per vendor
Read the full Etiometry Platform review

Implicity

  • Remote monitoring across Abbott, Biotronik, Boston Scientific, Medtronic, MicroPort
  • Three FDA 510(k) records, latest July 2026
  • SignalHF heart failure risk score
Read the full Implicity review

Score

Each row shows points earned of points available under the published rubric.

Etiometry Platform

38of 100

Competitive

Implicity

36of 100

Competitive
Score by dimension for Etiometry Platform and Implicity
DimensionEtiometry PlatformImplicityDifference
FDA clearance12 / 1212 / 120
HIPAA / SOC2 / BAA10 / 100 / 10+10
EHR integrations (count)0 / 5.60 / 5.60
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 4.80 / 4.80
Bidirectional write-back0 / 1.20 / 1.20
Peer-reviewed papers0 / 218.4 / 21-8.4
RCT / meta-analysis / systematic review0 / 90 / 90
Funding & adoption signal3 / 123 / 120
Pricing transparency1.3 / 2.51.3 / 2.50
Years in market6 / 66 / 60

Scroll horizontally to see every column.

How scores are computed

Pricing

Etiometry Platform

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price. Demo request only.

Implicity

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price.

Evidence

Etiometry Platform

FDA decisions

Show 6 more

Implicity

FDA decisions

Peer-reviewed

1 PubMed record names Implicity.

Compliance and integrations

Documented from each vendor’s own pages.

SpecEtiometry PlatformImplicity
Free tierNo / unverifiedNo / unverified
HIPAAYesNo / unverified
SOC 2 Type IIYesNo / unverified
EHR integrationsNot specifiedNot specified
Founded20102016
HQUSFR

Scroll horizontally to see both columns.

Common questions

Open the full decision support comparison

Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.